has knowledgeable contact person
is biomaterial used in
Bio Materials  >  Homo sapiens  >  4 melanoma patients

4 melanoma patients

Homo sapiens

Aiming at finding possible reasons for the discrepancies between our findings and published data could be the amount of ONTAK used in patients, we filed an amendment to the clinical trial allowing the inclusion of additional 4 patients. These patients will receive higher doses (12microg/kg 3x and 18microg/kg 1x) before vaccination. Taking into account direct effects of ONTAK on DC, patients will be vaccinated some days after last ONTAK treatment (as soon as blood DC have recovered to 50% of pre ONTAK amount).

Third stage of DERMA-ER-DC 05 clinical trial.



created over 7 years ago (16 December 2009)    last modified over 6 years ago (28 September 2011)   [ RDF Rdf ]   [ RelFinder Relfinder ]